J. E. Hoppe - Concepedia

Author

J. E. Hoppe

University Children's Hospital Tübingen

Also Known As

J E Hoppe, J. E. Hoppe, J. Hoppe, J.E. Hoppe, Jörg E. Hoppe, JÖRG E. HOPPE, Jörg E. Hoppe, Jörg Hoppe

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University Children's Hospital Tübingen Boston Children's Hospital University of Tübingen Institute of Medical Microbiology and Hygiene Universitätskinderklinik

About

J. E. Hoppe is an author at University Children's Hospital Tübingen specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	405
2	Health Sciences	4	4	90
3	Education	1	1	20
4	Public Health	1	1	101
5	Allergy	1	1	12

J. E. Hoppe

Publications

962

Citations

H-Index

Page 1

	Year	Citations
Efficacy of a two-component acellular pertussis vaccine in infants Johannes G. Liese, Carlton Meschievitz, E. Harzer, The Pediatric Infectious Disease Journal Pertussis CasesVaccine HesitancyPediatric EpidemiologyVaccine SurveillanceClinical Epidemiology	1997	101
Acute mastoiditis — Relevant once again J. E. Hoppe, S. Köster, D Niethammer, Infection	1994	90
Superior long-term graft function and better growth of grafts in children receiving kidneys from paediatric compared with adult donors Lars Pape, J. E. Hoppe, Thomas Becker, Nephrology Dialysis Transplantation	2006	82
Activity of new macrolides againstBordetella pertussis andBordetella parapertussis J. E. Hoppe, Astrid Eichhorn European Journal of Clinical Microbiology & Infectious Diseases Pertussis Andbordetella ParapertussisAntiparasitic Agent	1989	58
Evaluation of Six Commercial Tests and the Germ-Tube Test for Presumptive Identification of Candida albicans Perry A. Frey, J. E. Hoppe European Journal of Clinical Microbiology & Infectious Diseases Diagnostic MycologyAntifungal AgentCandida AlbicansVaginitisClinical Mycology	1999	53
In Vitro Susceptibilities of <i>Bordetella pertussis</i> and <i>Bordetella parapertussis</i> to Two Ketolides (HMR 3004 and HMR 3647), Four Macrolides (Azithromycin, Clarithromycin, Erythromycin A, and Roxithromycin), and Two Ansamycins (Rifampin and Rifapentine) J. E. Hoppe, A. Bryskier Antimicrobial Agents and Chemotherapy	1998	50
Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis J. E. Hoppe, U. Halm, H. Hagedorn, Infection PharmacologyErythromycin EthylsuccinateMedicineAntibiotics	1989	50
Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis J. E. Hoppe The Pediatric Infectious Disease Journal	1992	49
Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension J. E. Hoppe The Pediatric Infectious Disease Journal	1997	44
Compliance of German pediatric patients with oral antibiotic therapy: results of a nationwide survey J. E. Hoppe, Gunnar Blumenstock, W Grotz, The Pediatric Infectious Disease Journal	1999	39

Page 1